Squarepoint’s Osiris Therapeutics OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-29,620
Closed -$563K – 2853
2019
Q1
$563K Buy
+29,620
New +$480K 0.01% 1423

Other funds holding OSIR

Squarepoint's OSIR Position: Q2 2019 in Review

Squarepoint sold out of Osiris Therapeutics (OSIR) in Q2 2019, closing a stake of 29,620 shares — an estimated $563K sold.

Squarepoint first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $563K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Squarepoint reported no remaining Osiris Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Squarepoint sold 29,620 Osiris Therapeutics shares in Q2 2019, an estimated $563K.
  • Squarepoint first reported a position in Osiris Therapeutics in Q1 2019 and held it in 1 quarter.
  • Squarepoint's Osiris Therapeutics position peaked at $563K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics as of Q2 2019.

Based on Squarepoint's 13F filing for Q2 2019, filed 14 Aug 2019.